Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Antibiotics at the crossroads

Are we making the right choices to bring new drugs to the marketplace?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Projan, S. J. Curr. Opin. Microbiol. 6, 427–430 (2003).

    Article  Google Scholar 

  2. Wenzel, R. P. N. Engl. J. Med. 351, 523–526 (2004).

    Article  CAS  Google Scholar 

  3. Infectious Diseases Society of America. Bad Bugs, No Drugs; http://www.idsociety.org/Template.cfm?Section=Home&CONTENTID=7455&TEMPLATE=/ContentManagement/ContentDisplay.cfm (2004).

  4. Centers for Disease Control and Prevention. A Public Health Action Plan to Combat Antimicrobial Resistance; http://www.cdc.gov/drugresistance/actionplan/html/index.htm (2000).

  5. Coates, A., Hu, Y., Bax, R. & Page, C. Nature Rev. Drug Discov. 1, 895–910 (2002).

    Article  CAS  Google Scholar 

  6. World Health Organization Draft Global Strategy for the Containment of Antimicrobial Resistance; http://www.who.int/emc/amr.html (2001).

  7. Service, R. F. Science 303, 1796–1799 (2004).

    Article  Google Scholar 

  8. Walsh, C. Nature Rev. Microbiol. 1, 65–70 (2003).

    Article  CAS  Google Scholar 

  9. Miesel, L., Greene, J. & Black, T. A. Nature Rev. Genet. 4, 442–456 (2003).

    Article  CAS  Google Scholar 

  10. Global Alliance for Tuberculosis Drug Development. The Economics of TB Drug Development; http://www.tballiance.org/pdf/Economics%20Report%20Full%20(final).pdf (2001).

  11. Chopra, I., Hodgson, J., Metcalf, B. & Poste, G. J. Am. Med. Assoc. 275, 401–403 (1996).

    Article  CAS  Google Scholar 

  12. Darwin, K. H., Ehrt, S., Gutierrez-Ramos, J. C., Weich, N. & Nathan, C. F. Science 302, 1963–1966 (2003).

    Article  ADS  CAS  Google Scholar 

  13. Bryk, R., Lima, C. D., Erdjument-Bromage, H., Tempst, P. & Nathan, C. Science 295, 1073–1077 (2002).

    Article  ADS  CAS  Google Scholar 

  14. Schnappinger, D. et al. J. Exp. Med. 198, 693–704 (2003).

    Article  CAS  Google Scholar 

  15. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. Mol. Microbiol. 48, 77–84 (2003).

    Article  CAS  Google Scholar 

  16. Tong, A. H. et al. Science 303, 808–813 (2004).

    Article  ADS  CAS  Google Scholar 

  17. Fidock, D. A., Rosenthal, P. J., Croft, S. L., Brun, R. & Nwaka, S. Nature Rev. Drug Discov. 3, 509–520 (2004).

    Article  CAS  Google Scholar 

  18. Manetsch, R. et al. J. Amer. Chem. Soc. 126, 12809–12819(2004).

    Article  CAS  Google Scholar 

  19. Keller, M. & Zengler, K. Nature Rev. Microbiol. 2, 141–150 (2004).

    Article  CAS  Google Scholar 

  20. Liu, J. et al. Nature Biotechnol. 22, 185–191 (2004).

    Article  CAS  Google Scholar 

  21. Nwaka, S. & Ridley, R. G. Nature Rev. Drug Discov. 2, 919–928 (2003).

    Article  CAS  Google Scholar 

  22. Vennerstrom, J. L. et al. Nature 430, 900–904 (2004).

    Article  ADS  CAS  Google Scholar 

  23. World Health Organization, Commisssion on Macroeconomics and Health Macroeconomics and Health: Investing in Health for Economic Development; http://www.cmhealth.org (2001).

Download references

Acknowledgements

Thanks to A. Apt, K. Deitsch, H. Djaballah, B. Ganem, W. Jorgensen, T. Kapoor, M. MacCoss, V. Mizrahi, S. Projan, L. Quadri, K. Rhee, M. Rosenberg, D. Russell, D. Scheinberg, D. Schnappinger, D. Tan, T. Templeton and P. van Helden for stimulating discussions. Special thanks are due to P. Davies, S. Ehrt, M. Glickman, B. Kelly, J. McKinney and S. Nwaka.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nathan, C. Antibiotics at the crossroads. Nature 431, 899–902 (2004). https://doi.org/10.1038/431899a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/431899a

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing